This Research report 'Cosmetic Surgery Market in Asia' gives an overview of the Asian cosmetic surgery market as it stands today and details its evolution over the years. The report list out the key drivers of change as well as potential barriers to growth and also provides a future outlook and growth potential for cosmetic surgery in the region.

The report maps the different stages of market evolution for key individual countries in the region and provides an in-depth look at four Asian markets namely South Korea, Thailand, India and Singapore. The report provides market growth and key drivers of growth and barriers as well as key customer group profiles and trends for these countries.

Purchase a copy of this report @

Table Of Contents

Executive Summary
Asia Market Overview
Key Market Highlights
South Korea
Market Outlook & Recommended Research Areas

Complete report available @

Related Reports on Pharmaceuticals Market:

Deals in Oncology Personalized Medicine Industry - Worldwide Analysis: The Personalized Medicine in Oncology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the world’s leading healthcare companies in oncology sector. All the deals have been tracked year wise. All the deals have been covered under different chapters in below mentioned topics.

  • Collaboration Deals
  • Partnership Deals
  • Distribution Agreement Deals
  • Joint Venture Deals
  • Licensing Agreement Deals
  • Strategic Alliances Deals
  • Merger & Acquisition Deals
  • Co–Promotion Deals
  • Co–Marketing Deals
  • Co–Development Deals

Menopause Partnering 2009-2014: The Menopause Partnering 2009-2014 report provides understanding and access to the menopause partnering deals and agreements entered into by the worlds leading healthcare companies.

  • Trends in menopause partnering deals
  • Top menopause deals by value
  • Deals listed by company A-Z, industry sector, stage of development, technology type

Latest guidebook for Chinese Drug Recall Regulations (2014 Edition): China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. By 2013, total value of drugs on Chinese healthcare market has reached RMB 1114 billion.

United States and Japan - Proton Therapy Market, Patients & Forecast: Proton therapy has become a subject of considerable interest in the radiation oncology community and it is expected that there will be a substantial growth in proton treatment facilities during the next decade. Proton therapy, one of the most intriguing developments in cancer treatment, carries a price tag as intimidating as its size. At a cost of US$ 125 Million, and sometimes much more, today’s centers usually fill a city block. Building and equipping a facility carries financial and logistical challenges that dwarf nearly any other capital project. Even health care systems with deep pockets might not have sufficient land available, particularly in urban areas.